Topical tazarotene in acne vulgaris: Treatment approaches

Cutis

Volumn 74, Issue 4 SUPPL., 2004, Pages 16-21

  Anderson, Dina N ^a,f   Callender, Valerie D ^b,f,g   Del Rosso, James Q ^c,f,g,h,i   Tanghetti, Emil A ^d,f   Zane, Lee T ^e  

^a Downstate Health Sciences University   (United States)

^b Callender Skin and Laser Center   (United States)

^c UNIVERSITY OF NEVADA   (United States)

^d Center for Dermatology and Laser Surgery   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f ALLERGAN INC   (United States)

^g Galderma

^h The Dermatology Company   (United States)

ⁱ Stiefel Laboratories Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANDROGEN; ANTIBIOTIC AGENT; BENZOYL PEROXIDE; CLINDAMYCIN; GLYCOLIC ACID; HYDROQUINONE; ISOTRETINOIN; ORAL CONTRACEPTIVE AGENT; RETINOID; SALICYLIC ACID; TAZAROTENE; TRIAMCINOLONE;

ACNE VULGARIS; AFRICAN AMERICAN; AGE DISTRIBUTION; ASIAN AMERICAN; CLIMATE; CLINICAL PRACTICE; DISEASE SEVERITY; DRUG EFFICACY; DRUG FORMULATION; DRUG TOLERABILITY; DRUG USE; HUMAN; HUMIDIFIER; MAINTENANCE THERAPY; OCHRONOSIS; PERIODICITY; PRESCRIPTION; REVIEW; SKIN; SKIN CARE; SKIN IRRITATION;

ACNE VULGARIS; ADMINISTRATION, CUTANEOUS; ADOLESCENT; ADULT; AFRICAN AMERICANS; ASIAN AMERICANS; CLIMATE; DERMATOLOGIC AGENTS; DRUG ADMINISTRATION SCHEDULE; FEMALE; GELS; HUMANS; MALE; NICOTINIC ACIDS; PATIENT SATISFACTION; RETINOIDS; SKIN; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES; WEATHER;

EID: 7744225872     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (6)

1. Leyden JJ. A review of the use of combination therapies for the treatment of acne vulgaris. J Am Acad Dermatol. 2003;49(suppl 3):S200-S210.
2. White GM. Recent findings in the epidemiologic evidence, classification, and subtypes of acne vulgaris. J Am Acad Dermatol. 1998;39(suppl 2, pt 3):S34-S37.
3. Bulengo-Ransby SM, Griffiths CE, Kimbrough-Green CK, et al. Topical tretinoin (retinoic acid) therapy for hyperpigmented lesions caused by inflammation of the skin in black patients. N Engl J Med. 1993;328:1438-1443.
4. Lehmann HP, Robinson KA, Andrews JS, et al. Acne therapy: a methodologic review. J Am Acad Dermatol. 2002;47:231-240.
5. Leyden JJ. Meta-analysis of topical tazarotene in the treatment of mild to moderate acne. Cutis. 2004;74(supp 4):9-15.
6. Callender VD. Acne in ethnic skin: special considerations for therapy. Dermatol Ther. 2004;17:184-195.